Atovaquone-d4 is a deuterium-labeled Atovaquone, used as a medication to treat or prevent pneumocystis pneumonia, toxoplasmosis, malaria, and babesia. This compound can be utilized as a tracer and an internal standard for quantitative analysis. Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules for quantitation during drug development. Deuteration can affect the pharmacokinetic and metabolic profiles of drugs.
- Used as a tracer
- Used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS